
OPKO Health OPK
$ 1.15
-1.29%
Quarterly report 2025-Q2
added 07-31-2025
OPKO Health Long Term Debt Current 2011-2026 | OPK
Annual Long Term Debt Current OPKO Health
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.6 M | 13 M | 11.6 M | 11.6 M | 9.03 M | 12 M | - | 11.9 M | 12 M | 11.5 M | 13.5 M | 12.6 M | - | 8.76 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 13.5 M | 8.76 M | 11.7 M |
Long Term Debt Current of other stocks in the Diagnostics research industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M | ||
|
Aspira Women's Health
AWH
|
202 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M | ||
|
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
6.52 M | $ 16.76 | 4.42 % | $ 893 M | ||
|
Interpace Biosciences
IDXG
|
431 K | $ 2.2 | -4.35 % | $ 9.73 M | ||
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
662 K | $ 1.43 | 4.38 % | $ 1.9 M | ||
|
Exact Sciences Corporation
EXAS
|
33.6 M | - | - | $ 19.8 B | ||
|
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
1.66 M | $ 23.18 | 0.22 % | $ 644 M | ||
|
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
57.7 M | $ 177.87 | 1.25 % | $ 8.82 B | ||
|
Medpace Holdings
MEDP
|
23.2 M | $ 498.89 | 1.09 % | $ 14.4 B | ||
|
Danaher Corporation
DHR
|
199 M | $ 194.47 | 2.58 % | $ 139 B | ||
|
Myriad Genetics
MYGN
|
6.9 M | $ 4.59 | 5.4 % | $ 425 M | ||
|
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | ||
|
NeoGenomics
NEO
|
4.78 M | $ 7.95 | 3.38 % | $ 1.02 B | ||
|
Illumina
ILMN
|
79 M | $ 126.18 | 4.34 % | $ 20.1 B | ||
|
Fulgent Genetics
FLGT
|
1.44 M | $ 15.34 | 6.31 % | $ 464 M | ||
|
Guardant Health
GH
|
27.7 M | $ 80.98 | 3.03 % | $ 10.2 B | ||
|
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B | ||
|
Senseonics Holdings
SENS
|
496 K | $ 6.69 | 0.15 % | $ 279 M | ||
|
Anixa Biosciences
ANIX
|
41 K | $ 2.77 | 2.79 % | $ 89.9 K | ||
|
Biomerica
BMRA
|
358 K | $ 2.07 | -3.05 % | $ 4.75 M | ||
|
Invitae Corporation
NVTA
|
14.6 M | - | - | $ 21.2 M | ||
|
Koninklijke Philips N.V.
PHG
|
241 M | $ 28.52 | 0.76 % | $ 20 B | ||
|
ICON Public Limited Company
ICLR
|
24.3 M | $ 110.04 | 3.02 % | $ 9.08 B | ||
|
Soleno Therapeutics
SLNO
|
726 K | $ 52.64 | 0.01 % | $ 2.68 B | ||
|
Laboratory Corporation of America Holdings
LH
|
191 M | $ 263.77 | 1.09 % | $ 21.9 B | ||
|
Natera
NTRA
|
7.64 M | $ 199.3 | 3.25 % | $ 19.6 B | ||
|
Celcuity
CELC
|
54 K | $ 119.06 | 1.64 % | $ 5.57 B | ||
|
Lantheus Holdings
LNTH
|
3.8 M | $ 80.85 | 0.32 % | $ 5.46 B | ||
|
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | ||
|
Neuronetics
STIM
|
5.56 M | $ 1.37 | 1.11 % | $ 90.4 M | ||
|
Quest Diagnostics Incorporated
DGX
|
174 M | $ 190.84 | -0.36 % | $ 21.2 B | ||
|
Neogen Corporation
NEOG
|
5.64 M | $ 9.32 | -1.01 % | $ 2.02 B | ||
|
ENDRA Life Sciences
NDRA
|
129 K | $ 4.97 | 0.61 % | $ 3.91 M | ||
|
Organovo Holdings
ONVO
|
521 K | - | -2.3 % | $ 19.4 M |